INmune Bio (INMB) to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th

Go back to INmune Bio (INMB) to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
(NASDAQ: INMB) Delayed: 2.44 --0 (-0%)
Previous Close $2.44    52 Week High
Open $2.44    52 Week Low
Day High $2.44    P/E N/A 
Day Low $2.44    EPS
Volume 3,481